BridgeMD
New treatment option for Irritable Bowel Syndrome
Official title Defining Objective Markers of Compliance for Dietary Therapies in IBS
ClinicalTrials.gov ID: NCT07494968
What this study is testing
- What it's testing
- This research will investigate if a specific marker in your stool or urine can be used to track changes in your carbohydrate intake including fructo-oligosaccharide and mannitol intake
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients with IBS ( including diarrhea, mixed or constipation type) and without unexplained alarm features (rectal bleeding, weight loss, nocturnal...
- Aged 18-65 years at the time of screening
- IBS-SSS of at least 175 at baseline
You likely can't join if
- people adhering to a dietary treatment such as the low-fat diet, low FODMAP diet, or gluten-free diet, within the past 6 months. Those who are...
- people who are predicted to make changes to their baseline IBS medication(s), over-the-counter (OTC) therapy, exercise, diet (beyond what is...
- people with a known history of celiac disease, inflammatory bowel disease or microscopic colitis
- people with a history of an eating disorder requiring medical or behavioral treatment within the past 10 years.
- BMI \< 18.5
- people with prior small bowel or colonic surgery (other than appendectomy or cholecystectomy).
See the full eligibility criteria
- Patients with IBS ( including diarrhea, mixed or constipation type) and without unexplained alarm features (rectal bleeding, weight loss, nocturnal pain, nocturnal diarrhea). In presence of alarm symptoms, if they have...
- Aged 18-65 years at the time of screening
- IBS-SSS of at least 175 at baseline
- people adhering to a dietary treatment such as the low-fat diet, low FODMAP diet, or gluten-free diet, within the past 6 months. Those who are lactose intolerant will not be excluded from the study and will be allowed...
- people who are predicted to make changes to their baseline IBS medication(s), over-the-counter (OTC) therapy, exercise, diet (beyond what is advised), or initiate/make changes to other complementary therapy that could...
- people with a known history of celiac disease, inflammatory bowel disease or microscopic colitis
- people with a history of an eating disorder requiring medical or behavioral treatment within the past 10 years.
- BMI \< 18.5
- people with prior small bowel or colonic surgery (other than appendectomy or cholecystectomy).
- History of appendectomy or cholecystectomy in the last 6 months.
- Oral antibiotic use in the past 3 months
- Any planned significant changes in dietary or exercise regimen within 30 days prior to Screening or during the study.
- Currently pregnant or breastfeeding.
The study team makes the final eligibility decision.
Where it's taking place
- Ann Arbor, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ann Arbor, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.